Studies have demonstrated that GPNMB was capable of blocking T cell stimulation via direct cell-cell intercommunication of antigen-presenting cells (APCs) and T cells resulting in immunosuppressive milieu in gliomas (Figure 2) [110, 111]. This evidence concerns the gene GPNMB and central nervous system cancer.